Literature DB >> 11123786

Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.

B De Silva1, L Banney, W Uttley, R Luqmani, O Schofield.   

Abstract

Pseudoporphyria is characterized by erythema, blistering, and scarring on sun-exposed skin. Nonsteroidal antiinflammatory drugs (NSAIDs) are implicated in the etiology of this condition. In a 1-year prospective study of children attending the pediatric rheumatology clinic in Edinburgh we found a prevalence of pseudoporphyria of 10.9% in children taking NSAIDs for juvenile idiopathic arthritis. Naproxen was the most commonly implicated NSAID, independent of dosage. Blue/gray eye color was an independent risk factor for the development of pseudoporphyria. We would advise caution in prescribing naproxen in these children to prevent disfiguring facial scarring.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123786     DOI: 10.1046/j.1525-1470.2000.01827.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  8 in total

Review 1.  Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.

Authors:  Victoria C Ziesenitz; Tatjana Welzel; Madelé van Dyk; Patrick Saur; Matthias Gorenflo; Johannes N van den Anker
Journal:  Paediatr Drugs       Date:  2022-09-02       Impact factor: 3.930

2.  An evaluation of the utility of routine laboratory monitoring of juvenile idiopathic arthritis (JIA) patients using non-steroidal anti-inflammatory drugs (NSAIDs): a retrospective review.

Authors:  Sheetal S Vora; Christine E Bengtson; Grant D Syverson; James J Nocton
Journal:  Pediatr Rheumatol Online J       Date:  2010-04-14       Impact factor: 3.054

3.  Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients.

Authors:  I Sermet-Gaudelus; J C Souberbielle; I Azhar; J C Ruiz; P Magnine; V Colomb; C Le Bihan; D Folio; G Lenoir
Journal:  Arch Dis Child       Date:  2003-11       Impact factor: 3.791

Review 4.  Cutaneous drug reactions in children: an update.

Authors:  Kara Heelan; Neil H Shear
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

Review 5.  Photodermatitis for the Allergist.

Authors:  Samuel L Coffin; Jake E Turrentine; Ponciano D Cruz
Journal:  Curr Allergy Asthma Rep       Date:  2017-06       Impact factor: 4.919

6.  Systemic arthritis in children: a review of clinical presentation and treatment.

Authors:  R Gurion; T J A Lehman; L N Moorthy
Journal:  Int J Inflam       Date:  2011-12-25

7.  Early onset pauciarticular arthritis is the major risk factor for naproxen-induced pseudoporphyria in juvenile idiopathic arthritis.

Authors:  Susanne G Schäd; Andrea Kraus; Imme Haubitz; Jiri Trcka; Henning Hamm; Hermann J Girschick
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

8.  Cyclin G2, a novel target of sulindac to inhibit cell cycle progression in colorectal cancer.

Authors:  Hongyou Zhao; Bin Yi; Zhipin Liang; Ches'Nique Phillips; Hui-Yi Lin; Adam I Riker; Yaguang Xi
Journal:  Genes Dis       Date:  2020-11-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.